Arizona State Retirement System Increases Holdings in CME Group Inc. (NASDAQ:CME)

Arizona State Retirement System lifted its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 0.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 103,763 shares of the financial services provider’s stock after acquiring an additional 542 shares during the quarter. Arizona State Retirement System’s holdings in CME Group were worth $24,097,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Meyer Handelman Co. purchased a new stake in CME Group in the 4th quarter valued at approximately $6,144,000. Spire Wealth Management lifted its stake in CME Group by 37.4% in the 4th quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider’s stock valued at $307,000 after buying an additional 359 shares in the last quarter. AEGON ASSET MANAGEMENT UK Plc lifted its stake in CME Group by 19.3% in the 4th quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider’s stock valued at $75,730,000 after buying an additional 52,862 shares in the last quarter. Bank of Montreal Can lifted its stake in CME Group by 41.8% in the 3rd quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock valued at $224,432,000 after buying an additional 303,169 shares in the last quarter. Finally, Geode Capital Management LLC lifted its stake in CME Group by 1.8% in the 3rd quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock valued at $1,823,964,000 after buying an additional 142,692 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 1.0 %

Shares of CME Group stock opened at $254.48 on Thursday. The business has a 50-day moving average of $239.35 and a 200-day moving average of $230.06. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The company has a market capitalization of $91.70 billion, a PE ratio of 26.32, a P/E/G ratio of 6.76 and a beta of 0.57. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $258.78.

CME Group (NASDAQ:CMEGet Free Report) last announced its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. As a group, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group declared that its Board of Directors has approved a stock repurchase program on Thursday, December 5th that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the financial services provider to reacquire up to 3.4% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s board believes its stock is undervalued.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be paid a dividend of $1.25 per share. The ex-dividend date is Friday, March 7th. This is an increase from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a dividend yield of 1.96%. CME Group’s dividend payout ratio (DPR) is currently 51.71%.

Insider Activity

In other news, insider Julie Winkler sold 11,592 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the transaction, the insider now owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. This trade represents a 34.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Suzanne Sprague sold 1,500 shares of the stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the transaction, the chief operating officer now directly owns 8,036 shares in the company, valued at $2,063,885.88. The trade was a 15.73 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 17,076 shares of company stock worth $4,271,496 over the last ninety days. Corporate insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on CME shares. Oppenheimer increased their price target on CME Group from $258.00 to $269.00 and gave the stock an “outperform” rating in a research note on Thursday, February 13th. Citigroup lowered CME Group from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $255.00 to $250.00 in a research note on Monday, January 6th. Royal Bank of Canada increased their price target on CME Group from $235.00 to $269.00 and gave the stock a “sector perform” rating in a research note on Thursday, February 13th. Deutsche Bank Aktiengesellschaft reduced their price target on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Finally, Morgan Stanley upped their price objective on CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 19th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $236.13.

Read Our Latest Analysis on CME

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.